Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of bone-
modifying agents and inhibits angiogenesis agents. Although the pathogenesis of MRONJ is …

Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Abstract Purpose of Review Osteonecrosis of the jaw (ONJ) is a rare and severe necrotic
bone disease reflecting a compromise in the body's osseous healing mechanisms and …

Since the initial description of medication‐related osteonecrosis of the jaw (MRONJ) almost
two decades ago, the potential pathophysiology and risk factors have been elaborated on in …

Introduction. The management of bisphosphonate‐related osteonecrosis of the jaw
(BRONJ), with no evidence‐based guidelines, remains controversial. We aimed to evaluate …

Medication‐related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse effect of
antiresorptive medications administered for control of osseous malignancy, osteoporosis, or …

Consensus has yet to be reached about the prevention and treatment of medication‐related
osteonecrosis of the jaw (MRONJ), which is a treatment sequela of several antiresorptive …

Osteonecrosis of the jaw (ONJ), a rare, but potentially severe side effect of anti-resorptive
medications, presents as exposed bone in the maxillofacial region lasting for at least 8 …

Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

Objectives We aimed to investigate whether skeletal‐specific H‐type blood vessels exist in
alveolar bone and how they function in alveolar bone remodeling. Materials and Methods H …